David A. Siegel Xoma Corp Transaction History

Two Sigma Advisers, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$15.02 - $21.51 $256,766 - $367,713	-17,095 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$11.83 - $18.98 $69,797 - $111,982	-5,900 Reduced 25.66%	17,095 $254,000
Q1 2019 May 15, 2019	SELL	$11.95 - $15.53 $109,940 - $142,876	-9,200 Reduced 28.58%	22,995 $285,000
Q4 2018 Feb 14, 2019	BUY	$11.27 - $17.54 $32,739 - $50,953	2,905 Added 9.92%	32,195 $407,000
Q3 2018 Nov 14, 2018	SELL	$15.67 - $25.73 $1,488 - $2,444	-95 Reduced 0.32%	29,290 $515,000
Q2 2018 Aug 14, 2018	BUY	$19.68 - $25.28 $125,263 - $160,907	6,365 Added 27.65%	29,385 $614,000
Q1 2018 May 15, 2018	BUY	$19.86 - $35.92 $198,600 - $359,200	10,000 Added 76.8%	23,020 $466,000
Q4 2017 Feb 14, 2018	BUY	$19.71 - $36.79 $256,624 - $479,005	13,020	13,020 $464,000

6.5M

100

1.6K

Ticker XOMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,450,800
Market Cap $344M
Description
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnolog...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.